Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: A prospective, pilot study

PURPOSE: We conducted a prospective single-center study to evaluate the possibility of discontinuation of dutasteride after combination therapy with an alpha blocker for benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: We prospectively treated BPH patients with an alpha blocker and dutaste...

Descripción completa

Detalles Bibliográficos
Autores principales: Shindo, Tetsuya, Hashimoto, Kohei, Shimizu, Takashi, Itoh, Naoki, Masumori, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392030/
https://www.ncbi.nlm.nih.gov/pubmed/25874044
http://dx.doi.org/10.4111/kju.2015.56.4.305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392030/
https://www.ncbi.nlm.nih.gov/pubmed/25874044
http://dx.doi.org/10.4111/kju.2015.56.4.305

Ejemplares similares